Floatz logo

Dasatinib

Liver Fibrosis

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Small moleculePhase 1/2Active
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
89/ 100

Competitive context

26 Active assets in the Liver Fibrosis cohort.

Asset / SponsorPhaseRating
Entecavir
Tanta University
Phase 4BB
Peg-Intron
Beth Israel Deaconess Medical Center
Phase 4BB
COLCHICINUM
Zagazig University
Phase 4BB
Peg-Ifn
Beijing Friendship Hospital
Phase 4BB
Hydronidone
Beijing Continent Pharmaceutical Co, Ltd.
Phase 3BB

View all 50 →

Same molecule, other indications

Dasatinib is also rated in:

B-cell acute lymphoblastic leukemiaDormant
BB
Indicative ·
70 / 100
View asset →
chronic myeloid leukemiaDormant
BB
Indicative ·
68 / 100
View asset →
B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)Dormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →